A Phase I Study of Gemcitabine/Nab-Paclitaxel/S-1 Chemotherapy in Patients With Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma

BACKGROUND: Systemic chemotherapy is the primary treatment in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC). More effective treatment options are highly awaited. The aim of this study was to evaluate the toxicity and feasibility of gemcitabine/nab-paclitaxel/S-...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chen, Li, Xiaofen, Cheng, Ke, Cai, Zhaolun, Xiong, Junjie, Lv, Wanrui, Li, Ruizhen, Zhang, Pei, Cao, Dan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Trial Results
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322137/
https://www.ncbi.nlm.nih.gov/pubmed/35930304
http://dx.doi.org/10.1093/oncolo/oyac146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322137/
https://www.ncbi.nlm.nih.gov/pubmed/35930304
http://dx.doi.org/10.1093/oncolo/oyac146

Ejemplares similares